【正文】 te binder choice in incident hemodialysis patients[J]. Kidney Int ,2024,71:438441. [40] Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P,Block GA. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients[J].Kidney Int, 2024,71:802807. [41] Li L, Terry CM, Shiu YT, Cheung AK. Neointimal hyperplasia associated with synthetic hemodialysis grafts[J]. Kidney Int ,2024,74:12471261. [42] Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients[J]. Semin Dial ,2024,21:300307. [43] Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure[J]. N Engl J Med,1992,327:19121918.[44] Annuk M, Zilmer M, Lind L, Linde T, Fellstr?m B. Oxidative stress and endothelial function in chronic renal failure [J]. J Am Soc Nephrol,2024,12:27472752. [45] Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin,metabolic risk factors, and cardiovascular events among patients with endstage renal disease[J]. J Am Soc Nephrol,2024,13:134141. [46] DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E,Wahren J. Insulin resistance in uremia[J]. J Clin Invest,1981,67:563568. 第二十四頁，共二十七頁。 Page 25 [47] Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia[J]. Kidney Int,2024,62:15241538. [48] Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study[J]. Kidney Int ,1999,55:19451951. [49] Yilmaz MI, Carrero JJ, Ortiz A, et al. Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease[J]. Clin J Am Soc ephrol,2024,4:17161723. [50] Vallance P, Leone A, Calver A, Collier J, Moncada of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure[J]. Lancet,1992, 339:572575. [51] Passauer J, B252。ssemaker E, Range U, Plug M, Gross in vivo showing increase of baseline nitric oxide generation and impairment of endotheliumdependent vasodilation in normotensive patients on chronic hemodialysis[J]. J Am Soc Nephrol,2024,11:17261734. [52] Fissell WH, Roy S. The implantable artificial kidney[J].Semin Dial ,2024,22:665670. [53] Gura V, Macy AS, Beizai M, Ezon C, Golper TA. Technical breakthroughs in the wearable artificial kidney (WAK).Clin J Am Soc Nephrol ,2024,4:14411448. [54] Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts functioning artificial nephron system: the promise of nanotechnology[J]. Hemodial Int,2024,9:210217. [55] Rastogi A, Nissenson AR. Technological advances in renalreplacement therapy: five years and beyond[J]. Clin J Am Soc Nephrol ,2024,4:132136. [56] 劉志紅 .轉(zhuǎn)化醫(yī)學(xué) :醫(yī)學(xué)模式的轉(zhuǎn)化 ,醫(yī)學(xué)開展的方向 [J].腎臟病不透析腎移植雜志 ,2024,1:12. [57] Himmelfarb J and Alp Ikizler T. Medical Progress Hemodialysis[J].N Engl J Med,2024,363:18331845. 第二十五頁，共二十七頁。 Page 26 第二十六頁，共二十七頁。 內(nèi)容總結(jié) 回眸血液透析的過去、 展望未來。中分子溶質(zhì) (相對分子質(zhì)量 500～ 30000)去除對患者預(yù)后的影響爭論由來已久［ 13］。在尿毒癥毒素相關(guān)損害及如何通過透析最佳答案去除毒素等方面認(rèn)識還很淺薄。謝謝 第二十七頁，共二十七頁。